STONY BROOK, NY --(Marketwired - September 07, 2016) - Applied DNA Sciences (Applied DNA), Inc. (
First launched in 2015, "HomeGrown™ - Cotton Proudly Grown in the USA" uses the Applied DNA botanical SigNature ® T DNA to tag and test the long staple cotton fibers known as Upland cotton. Upland cotton is the most widely planted species of cotton in the United States, accounting for at least 97% of all cotton production, or roughly 7 billion pounds per year.
The Lonestar program is a new addition to existing programs that apply SigNature T DNA to Pima (known as PimaCott®, and to HomeGrown Upland programs that previously included Acala and Delta cottons. The three DNA-tagged types of HomeGrown Upland cotton now provide the full spectrum of variety required by cotton manufacturers. Adoption has already begun with merchants, ginners, manufacturers and retailers in India, Pakistan, Bangladesh, China, Turkey and the US.
"Given the global ambiguities in cotton sourcing, the demand for US cotton is getting stronger," said Dr. James Hayward, CEO of APDN. "We have proved that if you can tag cotton fibers before they leave the country, you can protect an entire supply chain. Sustainability and responsibility, in truth, begin at home. We believe that proof of origin for 100% of source cotton is the best way to exclude ethically-challenged cottons, that either misrepresent origin or quality, or worse, may benefit from human trafficking."
With the launch of HomeGrown Lonestar cotton, SigNature T DNA tags now provide full end-to-end traceability from the West Texas Plains to the retail shelf. Secure supply chain custody protocols, storage, sampling and testing procedures are required as part of the PimaCott and HomeGrown programs, enabling retailers and brands to be confident in the label claims they make on the products they sell to consumers.
About Applied DNA Sciences
We make life real and safe by providing botanical-DNA based security and authentication solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. Our patented DNA-based solutions can be used to identify, tag, track, and trace products, to help assure authenticity, traceability and quality of products. SigNature ® DNA describes the platform ingredient that is at the heart of a family of uncopyable, security and authentication solutions such as SigNature ® T and fiberTyping ® , targeted toward textiles and apparel, DNAnet ® , for anti-theft and loss prevention, and digitalDNA ® , providing powerful track and trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. We are also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.
Go to adnas.com for more information, events and to learn more about how Applied DNA Sciences makes life real and safe. Common stock listed on NASDAQ under the symbol APDN, and warrants are listed under the symbol APDNW.
Forward-Looking Statements
The statements made by APDN in this press release may be "forward-looking" in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K filed on December 14, 2015,and our subsequent quarterly report on Form 10-Q filed on February 10, 2016, May 12, 2016 and August 11, 2016 which are available at www.sec.gov . APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.
Investor contact: Debbie Bailey 631-240-8817 debbie.bailey@adnas.com media contact : Kristen Bujold 781-639-4924 kristenb@cgprpublicrelations.com program contact: MeiLin Wan 631-240-8849 meilin.wan@adnas.com web: www.adnas.com twitter: @APDN
